


























































































sorgte auf Grund des möglichen Einsatzes  für  therapeutische Zwecke  für großes  Interesse. 
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a b s t r a c t
The success of therapeutic nanoparticles depends, among others, on their ability to penetrate a tissue for
actually reaching the target cells, and their efficient cellular uptake in the context of intact tissue and
stroma. Various nanoparticle modifications have been implemented for altering physicochemical and
biological properties. Their analysis, however, so far mainly relies on cell culture experiments which only
poorly reflect the in vivo situation, or is based on in vivo experiments that are often complicated by
whole-body pharmacokinetics and are rather tedious especially when analyzing larger nanoparticle sets.
For the more precise analysis of nanoparticle properties at their desired site of action, efficient ex vivo sys-
tems closely mimicking in vivo tissue properties are needed.
In this paper, we describe the setup of organotypic tumor tissue slice cultures for the analysis of tissue-
penetrating properties and biological activities of nanoparticles. As a model system, we employ 350 lm
thick slice cultures from different tumor xenograft tissues, and analyze modified or non-modified
polyethylenimine (PEI) complexes as well as their lipopolyplex derivatives for siRNA delivery.
The described conditions for tissue slice preparation and culture ensure excellent tissue preservation
for at least 14 days, thus allowing for prolonged experimentation and analysis. When using fluorescently
labeled siRNA for complex visualization, fluorescence microscopy of cryo-sectioned tissue slices reveals
different degrees of nanoparticle tissue penetration, dependent on their surface charge. More impor-
tantly, the determination of siRNA-mediated knockdown efficacies of an endogenous target gene, the
oncogenic survival factor Survivin, reveals the possibility to accurately assess biological nanoparticle
activities in situ, i.e. in living cells in their original environment.
Taken together, we establish tumor (xenograft) tissue slices for the accurate and facile ex vivo assess-
ment of important biological nanoparticle properties. Beyond the quantitative analysis of nanoparticle
tissue-penetration, the excellent tissue preservation and cell viability also allows for the evaluation of
biological activities.
 2016 Elsevier B.V. All rights reserved.
1. Introduction
Nanoparticles are extensively explored for the efficient delivery
of therapeutic candidate molecules like nucleic acids. Their success
strongly depends on their potential to overcome biological barri-
ers, to mediate tissue penetration for actually reaching their target
cells and to facilitate cellular internalization (see e.g. [1] for
review). While in vitromonolayer cell culture experiments monitor
these requirements only poorly, animal models are barely suitable
as a screening platform due to high cost, complicated whole-body
pharmacokinetics, species differences and the evolving goal of
reducing animal experiments (3R concept).
Among nanoparticles for nucleic acid delivery,
polyethylenimine-based complexes have been well established
for in vitro and in vivo applications [2]. For altering physicochemi-
cal and, concomitantly, biological properties, various modifications
including PEGylation [3] or liposome-coating [4] have been intro-
http://dx.doi.org/10.1016/j.ejpb.2016.11.013
0939-6411/ 2016 Elsevier B.V. All rights reserved.
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duced, with the aim of shielding the otherwise positive surface
charge in order to improve efficacy, blood circulation half-life,
uptake specificity and/or biocompatibility. In many cases, how-
ever, in vivo results considerably differ from cell culture data [5],
thus emphasizing the need for powerful ex vivo test systems for
establishing structure-function relationships.
Organotypic slice cultures derived from rodent brain are widely
used in neuroscience due to their straightforward access for phar-
macological intervention. This approach has recently also been
extended towards tumor-derived slice cultures. Due to the possi-
bility to study tumor cells in their intact environment including
extracellular matrix and to directly apply test substances, they pro-
vide a unique tool to determine tissue responses to various stimuli
[6,7]. In sharp contrast, only few studies have employed nanopar-
ticles in tissue slice cultures so far. PLGA nanoparticles were used
for the specific MMP-9 inhibition through MMP-1 delivery in hip-
pocampal slice cultures [8] or for antisense inhibition of telom-
erase in human lung cancer tissue slices [9].
As analysis platform for the systematic assessment of nanopar-
ticles and nanoparticle modifications with regard to their biologi-
cal efficacies and other properties like tissue penetration, tissue
slices have not been explored.
In this proof-of-principle study, we establish slice cultures from
different tumor xenograft tissues as a model system for nanoparti-
cle analysis. As representative examples, we analyze biological
properties, namely tissue penetration and siRNA-mediated knock-
down efficacy, of PEI-based complexes.
2. Materials and methods
2.1. Materials
The tumor cell lines PC3 (prostate carcinoma) and U87
(glioblastoma) were obtained from the American type culture col-
lection (ATCC; Manassas, VA) and cultivated under standard condi-
tions (37 C, 5% CO2) in Iscove’s Modified Dulbecco’s Medium
(IMDM; Sigma, Taufkirchen, Germany), supplemented with 10%
fetal calf serum (FCS; Life Technologies, Darmstadt, Germany).
The identities of the cell lines were authenticated by DNA (STR)
profiling. The branched PEI F25-LMW (4–12 kDa) was prepared
as previously described [10]. 1,2-Dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) was purchased from Avanti Polar Lipids
(Alabaster, AL). PEG-PEI was synthesized by PEGylation of PEI
F25-LMW using MS(PEG)24 as described previously [11].
Alexa647-labeled siRNA was purchased from Qiagen (Hilden,
Germany), unmodified siRNAs were from Biospring (Frankfurt,
Germany) or Thermo Fisher (Waltham, MA) with sequences as
detailed in the Suppl. Information.
2.2. Tumor cell xenografting, tissue slice preparation and cultivation
For the generation of subcutaneous tumor xenografts, 5  106
PC3 or U87 cells in 150 ll PBS were injected into both flanks of
6–8 weeks old athymic nude mice (Crl:NU-Foxn1nu, Charles River
Laboratories, Sulzfeld, Germany). Animal studies were conducted
according to the national regulations of animal welfare and
approved by the local authorities (Landesdirektion Sachsen, Ger-
many). When the xenografts reached 8  8 mm (length width)
in size, mice were sacrificed, tumors were excised and directly sub-
jected to sectioning as described previously for head and neck
squamous cell carcinoma samples [6], with minor modifications.
In brief, tumor tissue was cut into cubes of 5  5  5 mm side
length using an autoclaved standard razor blade. The cubes were
placed on a pile of sterile filter membranes soaked with the prepa-
ration medium. To facilitate the cutting procedure and to obtain
appropriate slices, each cube was fixated by Histoacryl glue (Braun,
Melsungen, Germany). Slices of 350 lm thickness were prepared
by a tissue chopper (McIlwain TC752, Campden Instruments,
Loughborough, UK, or Saur, Reutlingen, Germany). After cutting,
the slices were placed in a container with preparation medium
composed of MEM (Gibco Thermo Fisher) + 1% penicillin/strepto-
mycin. The adherent glue was removed and slices sticking together
were carefully separated by using two scalpels under a stereomi-
croscope. Slices were placed on membrane culture inserts using
the wide opening of a glass pipette with the fine tip broken off,
and residual preparation medium was removed with a normal pip-
ette. Slices were placed in groups of three per membrane and cul-
tivated in 6-well plates, each filled with 1 ml cultivation medium.
The cultivation medium was composed of MEM, 25% Hank’s
Balanced Salt Solution (with Ca and Mg; Gibco), 10% Normal horse
serum (Gibco), 1% penicillin/streptomycin, 1% L-glutamine, and
0.45% glucose. For cultivation, plates were kept in a humidified
incubator at 37 C and 5% CO2. The cultivation medium was
replaced 24 h after preparation and then every other day.
2.3. Complex preparation and analysis
PEI/siRNA and PEG-PEI/siRNA complexes were prepared by
mixing 15 lg siRNA with 112.5 lg PEI F25-LMW or 75 lg
PEG-PEI, each dissolved in 37.5 ll 10 mM HEPES/150 mM NaCl,
pH 7.4 and incubated for 10 min. After mixing and vortexing, the
complexation was allowed to proceed for 30 min at room temper-
ature. Lipopolyplexes were generated as described previously [4].
Briefly, DPPC liposomes were prepared by hydration of a dried lipid
film in an ultrasound bath sonicator and extrusion, and then mixed
with preformed PEI/siRNA complexes at a lipid/PEI mass
ratio = 1.7. After vigorous pipetting, the mixture was vortexed
and incubated for 60 min at room temperature prior to use.
Zeta potentials and particle sizes were determined by phase
analysis light scattering (PALS) and photon correlation spec-
troscopy (PCS) with a Brookhaven ZetaPALS system (Brookhaven
Instruments, Holtsville, USA), upon diluting the complexes to
1.5 ml in pure water. The manufacturer’s software was used for
data analysis, with applying a viscosity and refractive index of pure
water at 25 C. For size measurement, the complexes were ana-
lyzed in five runs with a run duration of 1 min, and results are
expressed as intensity weighted mean diameter. Zeta potentials
were determined in ten runs, with each run containing ten cycles,
and applying the Smoluchowski model. Bars represent mean ±SD
of the individual readings.
2.4. Tissue slice treatment, tissue slice analysis and determination of
tissue penetration
Slices were cultivated in the incubator as described above for
24 h prior to treatment with PEI-based complexes. 75 ll of the
complexes, i.e. approximately 3 drops per slice, were applied using
a 100 ll-pipette. The slices were then further cultivated for 24 h,
unless indicated otherwise.
To obtain a time series for the evaluation of histology, the slices
were fixed for 24 h in 4% paraformaldehyde prior to embedding in
paraffin. 7 lmsectionswere dewaxed and rehydrated in decreasing
alcohol series, stainedwith hematoxylin/eosin (H&E) and visualized
with a Zeiss Axioplan 2microscope using 20 and 40 objectives to
examine themorphology of the cultivated tissue. For immunohisto-
chemistry, the deparaffinized sections were washed 3 times for
10 min in phosphate buffered saline (PBS), treated with 1.5% Triton
X-100/PBS for 10 min for permeabilization and blocked with 10%
normal goat serum in 1.5% Triton X-100/PBS for at least 1 h. Primary
antibodies against the proliferation marker Ki67 (rabbit, 1:100;
DCS, Hamburg, Germany) or cleaved caspase-3 (rabbit, 1:400; Cell
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Signaling Technology, Danvers, MA) were applied and the slides
were incubated overnight at 4 C, prior to washing. For visualiza-
tion, the slides were incubated with Alexa 568-labeled goat anti-
rabbit secondary antibodies. Nuclei were counterstained with
Hoechst 33342 (Molecular Probes, Leiden, The Netherlands). Pic-
tures were taken using an Olympus BX40 fluorescent microscope
equipped with a 20 objective, and 36 pictures from six different
sections per nanoparticle type were analyzed bymanual cell count-
ing for Ki67, caspase-3 and Hoechst 33342 positive cells. Ki67 and
caspase-3 positive cells are shown as percentage of all cells, deter-
mined by Hoechst 33342 staining of cell nuclei.
For the detection of fluorescently labeled complexes, the
paraformaldehyde-fixed slices were washed in phosphate buffered
saline and soaked in sucrose solutions of increasing concentration
(10, 20, 30%) in the dark. The slices were positioned in small plastic
containers filled with Tissue-Tek (Sakura) and frozen by placing
them in dry ice. Vertical 12 lm sections of the slices were prepared
using a cryostat at 20 C, washed, and nuclei were counterstained
with Hoechst 33342.
From each 12 lm section, five z-stacks at 2 lm intervals were
taken with a confocal microscope (Zeiss LSM 700, Objective 20)
and converted to one projection to obtain high quality pictures
for analysis. Quantification of fluorescent pixels was performed
using Image J, and the calculated total area was then corrected
for differences in surface lengths in order to only represent diffu-
sion lengths. For each nanoparticle type, 8 samples were analyzed:
2 12-lm sections per slice  1 out of 3 slices per well  2 wells per
tumor  2 tumors, resulting in a total of 40 pictures.
2.5. Determination of Survivin levels by RT-qPCR
Total RNA was isolated from tissue slices using TRI Reagent
(Sigma-Aldrich) according to the manufacturer’s protocol. 1 lg
total RNA was reverse transcribed using RevertAidTM H Minus First
Strand cDNA Synthesis Kit (Fermentas, St. Leon-Roth, Germany)
and random hexamer primers. Quantitative PCR was performed
using a LightCycler 2.0 (Roche, Mannheim, Germany) and the
AbsoluteTM QPCR SYBR Green Capillary Mix (Thermo Scientific).
Survivin-specific primers were purchased from Eurofins MWG
Operon (see Suppl. Information for sequences). Quantitation of
gene expression was performed by the DDCt method with
b-actin as reference housekeeping gene.
3. Results and discussion
3.1. Tissue slice preparation and cultivation
350 lm tissue slices were prepared from pieces of different
tumor xenografts. Independent of tissue texture (PC3 cells form
harder xenografts than U87 cells (A. Aigner, personal observation)),
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Fig. 1. (A) Scheme of tissue slice preparation and cultivation (left) and corresponding original pictures (right), modified from [6]. (B) H&E stains of representative paraffin
sections from PC3 prostate carcinoma xenograft tissue slices at several time points after cultivation start. Tissue integrity and viability is well preserved. (C, D) No increase in
caspase-dependent apoptosis or decrease in proliferation is observed, as indicated by cleaved-caspase-3 (C, red) or Ki-67 (D, red) staining vs. all nuclei (blue). Left panels:
quantitation of multiple sections and microscopic fields (see Materials and Methods for details); right panels: representative pictures. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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above. Slices were transferred onto membrane inserts within six-
well plates for further cultivation (Fig. 1A). Morphological analysis
by H&E staining on paraffin sections of the tissue slices did not
reveal changes in tissue quality or integrity over the whole obser-
vation period of 14 days, and no necrotic processes were found
(Fig. 1B). No gradient between the outer surface and inner tissue
areas that could possibly result in cell death or other adverse
effects was observed (data not shown). Initial heterogeneity of
the sections, representing areas of different stroma density or
invading immune cells, was maintained throughout the whole cul-
tivation period (see e.g. Fig. 1B, d14). This was true for PC3 (Fig. 1B)
as well as for U87 tissue slices (Suppl. Fig. 1). Preservation of tissue
viability was also confirmed by cleaved caspase-3 staining for the
evaluation of apoptosis. The occurrence of apoptotic cells, here
assessed by evaluating only caspase-dependent apoptosis, was
low and did not increase upon cultivation, as determined by the
percentage of caspase-3 positive cells (1–2% of the whole cell
population; Fig. 1C). In line with this, no changes in the number
of proliferating cells (2–3% Ki-67 positive cells in the whole cell
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Fig. 2. (A) Tissue penetration of different PEI F25-LMW-based complexes, containing Alexa647-labeled siRNA for visualization by fluorescence microscopy. Two
representative sections are shown. Complexes were applied on the upper surface of slices and vertical cryo-sections were prepared after 24 h. Blue: cell nuclei (Hoechst
33342). PEG-PEI/siRNA complexes with low zeta potential show deeper penetration into the tissue than PEI/siRNA complexes; see also (B) the segment magnifications. (C)
Fluorescing areas indicating nanoparticle diffusion, quantitated as described in the Materials and Methods. A representative out of several experiments is shown, based on the
quantitation of 40 pictures per nanoparticle. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
48 L. Merz et al. / European Journal of Pharmaceutics and Biopharmaceutics 112 (2017) 45–50
3.2. Tissue penetration of polymer-based nanoparticles with different
surface charge
Tissue penetration and cellular uptake remains a major issue in
nanoparticle treatment. PEI-based complexes have been well
established for the efficient delivery of nucleic acids in vitro and
in vivo (see e.g. [2,10] for review). This is in part due to their
positive surface charge, which allows for their interaction with
negatively charged heparansulphate proteoglycans on the cell
surface and mediates cell internalization. However, this strong
interaction may impair tissue penetration, thus limiting nanoparti-
cle availability in deeper tissue areas. To address this question, we
compared complexes based on the low molecular weight PEI
F25-LMW [10] vs. derivatives prepared by the PEGylation of the
same PEI [11] or the addition of DPPC to the complex for lipopoly-
plex formation [4]. All nanoparticles are sufficiently stable for
siRNA complexation (not shown) and comparable in size, with
hydrodynamic diameters between 200 nm (PEG-PEI complexes,
lipopolyplexes) and 250 nm (PEI complexes; Suppl. Fig. 2A). In
contrast, major differences were observed in zeta potentials (Suppl.
Fig. 2B). For complex visualization, Alexa647-labeled siRNA was
used. At 24 h after PEI/siRNA complex application onto the surface
of the tissue slices, the analysis of cross sections by fluorescence
microscopy revealed initial penetration into deeper tissue areas
(Fig. 2A, upper panel). Cellular uptake of complexes was observed
as well. The depth of tissue penetration was independent of the
density of the nuclei, but sometimes varied between different parts
of the slice (see e.g. Fig. 2A, lower panel left vs. right). In contrast to
their non-PEGylated counterparts, PEG-PEI/siRNA complexes pene-
trated deeper into the tissue (Fig. 2A, center; see also Fig. 2B for
segment magnification and Fig. 2C for quantitation), despite the
majority of the complexes still being located on the tissue surface,
i.e. at the site of application. DAPI/Alexa647 co-localization
revealed cellular uptake to a lesser extent, being in line with the
lower zeta potential and poorer transfection efficacy of PEG-PEI
complexes in vitro [3]. DPPC lipopolyplex formation, albeit largely
shielding the surface charge of the PEI complexes (Suppl. Fig. 2),
has been shown previously to preserve transfection efficacy
in vitro [4], also allowing for the use of lipopolyplexes in vivo
[12]. Indeed, tissue penetration of the lipopolyplexes was compa-
rable to their corresponding PEI complexes (Fig. 2A; see Fig. 2C
for quantitation).
3.3. Assessment of biological activities of nanoparticles in tissue slices
Beyond tissue penetration, the cellular uptake and intracellular
release of the payload (here: siRNA) in the correct cell compart-
ment are critical steps. Thus, we next asked whether the tissue
slices allow for the determination of nanoparticle activity by mea-
suring of knockdown efficacies upon siRNA delivery. An siRNA tar-
geting the oncogenic survival factor Survivin, which is expressed in
both cell lines and thus also in the xenograft tissue, was selected.
96 h after single application of PEI/siSurv onto PC3 xenograft tissue
slices, an almost 50% knockdown of Survivin on the mRNA level
was observed in the tissue lysates (Fig. 3A). To exclude non-
specific knockdown effects, results were compared in all biological
studies to tissue slices identically treated with the same nanopar-
ticles containing a negative control siRNA against an irrelevant
gene product (siLuc). Despite their relatively large size
(300 nm; see Suppl. Fig. 2), this relatively high knockdown effi-
cacy indicates that PEI/siRNA complexes reach deeper regions
since the transfection of cells only in the upper layers cannot alone
account for the observed overall Survivin reduction. Since this
ex vivo model is devoid of blood flow, this can only be achieved
by rather efficient tissue penetration, probably reaching even dee-
per than what initially observed by fluorescence microscopy
(Fig. 2). In this context, it should also be noted that rather small
amounts of siRNA have been shown to be already sufficient for
RNAi-mediated knockdown (<2000 copies; [13]). This suggests that
fluorescence-assisted visualization may rather underestimate tis-
sue penetrating properties and that the assessment of biological
(knockdown) activities in tissue slices may be the more sensitive
readout. Comparable knockdown results were obtained in U87
glioblastoma xenograft tissue slices (Fig. 3C, left). Lipopolyplexes
showed similar efficacy, being in line with very good knockdown
results in previous cell culture experiments [4,12]. However, it
should be noted that results varied between different experiments,
suggesting more detailed analyses with regard to optimal condi-
tions for achieving reproducible knockdown results. Apart from tis-
sue slices, sources of variability may be the choice of the target
gene or the protocol for RNA preparation that will require analyses
beyond the scope of this paper (Ewe, Höbel, unpublished
observations).
Taken together, this study demonstrates the usefulness of
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Fig. 3. Measurement of biological activities of nanoscale complexes in tissue slices. (A) Determination of mRNA levels of the oncogenic survival factor Survivin at 96 h after
application of PEI/siRNA complexes onto PC3 prostate carcinoma xenograft tissue slices. The complexes containing the Survivin-specific siRNA (siSurv) mediate an almost 50%
knockdownas compared to tissue slices identically treatedwith PEI-complexedunrelated siRNA (siLuc) as negative control. (B) Comparison of knockdownefficacies of PEI/siRNA
complexes (left) and lipopolyplexes in U87 glioblastoma xenograft tissue slices. Bars represent means of 2–3 experiments with quantitation being done in duplicates.
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the tissue-penetrating properties of nanoparticles. Beyond
nanoparticle localization by fluorescence, excellent tissue preser-
vation and cell viability also allows for the evaluation of biological
activities. This model system can thus be used in larger screening
studies for establishing structure-function relationships, con-
tribute to the 3R principle in reduction of animal experiments
and precisely determine nanoparticle properties at their intended
site of action in vivo, without the complexity of large animal stud-
ies. Our data also provide the avenue for analyses in other tissues,
e.g. human primary tumors that mimic the situation in patients
more closely.
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morzellen darstellt.  Es  gelang der Nachweis  eines durch PEI‐siRNA‐Komplexe  vermittelten 
Knockdowns dieses Survivin Gens. 
Insgesamt gelang uns die Etablierung von Gewebeschnittkulturen als Grundlage  für die ex‐
vivo Untersuchung von Nanopartikeln. Es können nicht nur Aussagen über die Gewebepenet‐
ration der Nanopartikel, sondern auch über ihre biologischen Aktivitäten in einer intakten Ge‐
webestruktur getroffen werden. 
Trotz dieser ersten erfolgreichen Untersuchung  von Nanopartikeln mit Hilfe  von Gewebe‐
schnittkulturen ist in Zukunft ein besseres Verständnis der Verteilung der Komplexe auf dem 
Gewebe und der Gewebepenetration erforderlich. Die negative Ladung der Nanopartikel er‐
möglicht eine effizientere Interaktion mit Zellen und eine bessere Aufnahme, sie verhindert 
jedoch das Eindringen  in tiefere Gewebsschichten.  Im hier durchgeführten Knockdown des 
endogenen Genproduktes Survivin zeigte sich ein Abschalten von 50 % der Gene. Dieses Er‐
gebnis korreliert somit nicht mit der sich histologisch darstellenden floureszierenden Fläche. 
Eine verbesserte Quantifizierung der Gewebetiefe ist somit von höchster Relevanz. Ein weite‐
rer Ansatzpunkt für zukünftige Projekte  ist die Frage nach der tatsächlichen zellulären Auf‐
nahme und der Freisetzung der siRNA im korrekten Zellkompartiment. Ein weiterer Schritt zur 
Etablierung der Methode ist die Anwendung der PEI‐Komplexe an humanen Tumorbiospien.  
6 Zusammenfassung und Ausblick    35 
 
Zusammenfassend  lässt sich sagen, dass Schnittkulturen von PC3/U87 Zelllinien ein stabiles 
präklinisches Tumormodell darstellen. Tumormorphologie und Mikroumgebung bleiben wei‐
testgehend erhalten. Anhand der Xenograft‐Modelle kann das Verhalten der mit PEI komple‐
xierten kleinen RNA‐Moleküle detailliert untersucht werden. Es können sowohl neue Thera‐
pie‐Targets als auch verschiedene Therapieformen analysiert werden. Da das Einsatzspektrum 
der Komplexe theoretisch alle Krankheiten umfasst, welche auf einer Veränderung von Gen‐
abschnitten beruhen, wäre ihre effiziente therapeutische Anwendung ein großer Erfolg. 
 
